In the news ShapeTX in the News Company News Media Mentions Blog News and Publications Company News See All September 7, 2023 Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases June 20, 2023 ShapeTX Announces the Appointment of Adrian W. Briggs, Ph.D. As Chief Technology Officer May 4, 2023 ShapeTX Announces Seven Presentations at ASGCT 2023 Showcasing the Potential of Generative AI and RNA in CNS Disorders and Beyond Media Mentions See All 23 Top Biotech Startups According to VCs (Business Insider, July 28, 2022) Fierce Biotech’s 2022 Fierce 15 (Fierce Biotech, September 12, 2022) Pushing Beyond Gene Editing Limits with Programmable RNA Medicines (Biospace, June 13, 2022) Blog See All How AI will revolutionize drug discovery: ShapeTX CEO Francois Vigneault on Tech Nation Spotlight Video: Solving puzzles as a team Generative AI is creating the next generation of therapies: programmable medicine ShapeTX at ASGCT 2023: Programmable Medicine Takes Center Stage Spotlight Video: Charting New Courses Dispatches from The Atlantic Progress Summit: How mRNA Technology Could Save the World News and Publications See All
